Figure 5.
VT treatments of Jurkat-C cells significantly reduce subsequent HIV-1IIIB infection. (a) JKT-C cells were treated for 3 days with VT1 or VT2 (1 µg/mL) and the toxins were removed by washing with culture media prior to infection with HIV-1IIIB (m.o.i. = 0.1). Post infection supernatants were collected at day 7 and HIV-1 viral production was measued by p24gag ELISA (b) A time course was conducted to determine the minimum preincubation time required for VT1 treatment to achieve viral reduction. p24 measured on day 6. Error bar represents standard error mean (n = 4). One hour pretreatment was sufficient.